Total Payments
$10,678
2024 Payments
$1,363
Companies
52
Transactions
420
Medicare Patients
15,165
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$9,466 (88.7%)
Travel$1,043 (9.8%)
Other$113.64 (1.1%)
Education$55.00 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,466 | 413 | 88.7% |
| Travel and Lodging | $1,043 | 5 | 9.8% |
| Grant | $113.64 | 1 | 1.1% |
| Education | $55.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NeoTract Inc. | $2,075 | 27 | $0 (2020) |
| Astellas Pharma US Inc | $1,631 | 93 | $0 (2022) |
| ABBVIE INC. | $1,033 | 57 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $790.24 | 24 | $0 (2024) |
| Boston Scientific Corporation | $635.33 | 16 | $0 (2022) |
| Teleflex LLC | $494.26 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $464.99 | 23 | $0 (2024) |
| Blue Earth Diagnostics Limited | $370.60 | 20 | $0 (2024) |
| Myovant Sciences Inc. | $319.97 | 16 | $0 (2022) |
| PROCEPT BioRobotics Corporation | $172.46 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,363 | 57 | ABBVIE INC. ($271.29) |
| 2023 | $1,065 | 39 | ABBVIE INC. ($247.41) |
| 2022 | $1,004 | 60 | Myovant Sciences Inc. ($167.37) |
| 2021 | $1,733 | 77 | Astellas Pharma US Inc ($322.64) |
| 2020 | $525.94 | 31 | Astellas Pharma US Inc ($282.01) |
| 2019 | $2,382 | 58 | NeoTract Inc. ($1,452) |
| 2018 | $1,482 | 55 | NeoTract Inc. ($561.09) |
| 2017 | $1,124 | 43 | Astellas Pharma US Inc ($451.54) |
All Payment Transactions
420 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/11/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/11/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/21/2024 | CIVCO Medical Instruments | — | Food and Beverage | Cash or cash equivalent | $19.07 | General |
| 11/14/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: OS | ||||||
| 11/14/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: HORMONE THERAPY | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/21/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $23.60 | General |
| Category: UROLOGY | ||||||
| 10/17/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.21 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/15/2024 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $32.47 | General |
| Category: Urology | ||||||
| 10/10/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $34.40 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/03/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $34.39 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/26/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $16.20 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/12/2024 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: ONCOLOGY | ||||||
| 08/27/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Diagnostic Imaging | ||||||
| 08/22/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/16/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/08/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/24/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/12/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $34.71 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/28/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 4,079 | 5,722 | $826,903 | $260,059 |
| 2022 | 38 | 3,855 | 5,018 | $839,620 | $280,246 |
| 2021 | 40 | 3,582 | 4,638 | $780,741 | $291,690 |
| 2020 | 45 | 3,649 | 5,195 | $882,950 | $345,192 |
Total Patients
15,165
Total Services
20,573
Medicare Billing
$1.2M
Procedure Codes
162
All Medicare Procedures & Services
162 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 576 | 728 | $204,862 | $62,500 | 30.5% |
| J1952 | Leuprolide injectable, camcevi, 1 mg | Office | 2023 | 11 | 504 | $97,725 | $33,545 | 34.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 133 | 146 | $79,238 | $26,208 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 341 | 376 | $76,767 | $23,698 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 191 | 191 | $70,023 | $21,992 | 31.4% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 31 | 31 | $49,523 | $17,080 | 34.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 69 | 76 | $30,356 | $9,779 | 32.2% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2023 | 39 | 135 | $42,120 | $9,288 | 22.1% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 347 | 391 | $15,984 | $7,037 | 44.0% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 32 | 32 | $9,971 | $3,475 | 34.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 664 | 952 | $7,414 | $3,223 | 43.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 19 | 19 | $9,260 | $3,144 | 34.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 399 | 493 | $6,231 | $3,111 | 49.9% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2023 | 39 | 90 | $31,581 | $3,095 | 9.8% |
| 87529 | Detection test by nucleic acid for herpes simplex virus, amplified probe technique | Office | 2023 | 39 | 90 | $17,545 | $3,095 | 17.6% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 39 | 90 | $10,527 | $3,095 | 29.4% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 16 | 16 | $7,979 | $2,837 | 35.6% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 92 | 100 | $5,736 | $2,500 | 43.6% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 119 | 137 | $5,601 | $2,469 | 44.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 242 | 304 | $7,323 | $2,328 | 31.8% |
| 87496 | Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique | Office | 2023 | 39 | 45 | $3,509 | $1,548 | 44.1% |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | Office | 2023 | 39 | 45 | $3,509 | $1,548 | 44.1% |
| 87532 | Detection test by nucleic acid for herpes virus-6, amplified probe technique | Office | 2023 | 39 | 45 | $3,509 | $1,548 | 44.1% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2023 | 39 | 45 | $3,509 | $1,548 | 44.1% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 39 | 45 | $3,509 | $1,548 | 44.1% |
About Dr. Frank Moore, MD
Dr. Frank Moore, MD is a Urology healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1477549863.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Moore, MD has received a total of $10,678 in payments from pharmaceutical and medical device companies, with $1,363 received in 2024. These payments were reported across 420 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($9,466).
As a Medicare-enrolled provider, Moore has provided services to 15,165 Medicare beneficiaries, totaling 20,573 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 162 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Fort Worth, TX
- Active Since 09/21/2005
- Last Updated 06/03/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1477549863
Products in Payments
- UroLift (Device) $1,635
- PROVENGE (Drug) $908.70
- UROLIFT (Device) $632.13
- MYRBETRIQ (Drug) $571.46
- ORGOVYX (Drug) $507.28
- XTANDI (Drug) $434.73
- Myrbetriq (Drug) $433.28
- LUPRON DEPOT (Drug) $412.20
- BOTOX (Biological) $330.50
- GREENLIGHT (Device) $290.36
- UroLift System (Device) $288.79
- Axumin (Drug) $268.85
- ERLEADA (Drug) $193.99
- ELIGARD (Drug) $154.24
- Lupron (Drug) $141.43
- AQUABEAM ROBOTIC SYSTEM (Device) $134.28
- GEMTESA (Drug) $130.02
- PYLARIFY (Drug) $128.76
- Nubeqa (Drug) $121.25
- JELMYTO (Drug) $119.80
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Fort Worth
Dr. Adam Hollander, M.d, M.D
Urology — Payments: $34,688
Urology $34,688
Dr. Michael Waters, D.o, D.O
Urology — Payments: $30,841
Urology $30,841
Todd Young, Do, DO
Urology — Payments: $27,420
Urology $27,420
David Rittenhouse, Do, DO
Urology — Payments: $23,999
Urology $23,999
Scott Thurman, Md, MD
Urology — Payments: $17,845
Urology $17,845
Dr. Wayne Hey, D.o, D.O
Urology — Payments: $10,405
Urology $10,405